Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Recurrent Urinary Tract Infections in Children With Bladder and Bowel Dysfunction.

Shaikh N, Hoberman A, Keren R, Gotman N, Docimo SG, Mathews R, Bhatnagar S, Ivanova A, Mattoo TK, Moxey-Mims M, Carpenter MA, Pohl HG, Greenfield S.

Pediatrics. 2016 Jan;137(1). doi: 10.1542/peds.2015-2982. Epub 2015 Dec 8.

2.

Risk Factors for Recurrent Urinary Tract Infection and Renal Scarring.

Keren R, Shaikh N, Pohl H, Gravens-Mueller L, Ivanova A, Zaoutis L, Patel M, deBerardinis R, Parker A, Bhatnagar S, Haralam MA, Pope M, Kearney D, Sprague B, Barrera R, Viteri B, Egigueron M, Shah N, Hoberman A.

Pediatrics. 2015 Jul;136(1):e13-21. doi: 10.1542/peds.2015-0409. Epub 2015 Jun 8.

3.

Renal Scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial.

Mattoo TK, Chesney RW, Greenfield SP, Hoberman A, Keren R, Mathews R, Gravens-Mueller L, Ivanova A, Carpenter MA, Moxey-Mims M, Majd M, Ziessman HA; RIVUR Trial Investigators.

Clin J Am Soc Nephrol. 2016 Jan 7;11(1):54-61. doi: 10.2215/CJN.05210515. Epub 2015 Nov 10.

4.

Sonographic assessment of the effect of vesicoureteral reflux and urinary tract infections on growth of the pediatric solitary kidney.

Ross I, Ahn HJ, Roelof B, Barber T, Huynh V, Rockette A, Popovic M, Chen JJ, Steinhardt G.

J Pediatr Urol. 2015 Jun;11(3):145.e1-6. doi: 10.1016/j.jpurol.2015.02.012. Epub 2015 Mar 13.

5.

Computer model predicting breakthrough febrile urinary tract infection in children with primary vesicoureteral reflux.

Arlen AM, Alexander SE, Wald M, Cooper CS.

J Pediatr Urol. 2016 Oct;12(5):288.e1-288.e5. doi: 10.1016/j.jpurol.2016.03.005. Epub 2016 Mar 31.

PMID:
27072485
6.

Incidence of febrile urinary tract infections in children after successful endoscopic treatment of vesicoureteral reflux: a long-term follow-up.

Hunziker M, Mohanan N, D'Asta F, Puri P.

J Pediatr. 2012 Jun;160(6):1015-20. doi: 10.1016/j.jpeds.2011.12.033. Epub 2012 Jan 28. Erratum in: J Pediatr. 2012 Jul;161(1):175.

PMID:
22284917
7.

Vesicoureteral reflux--the role of bladder and bowel dysfunction.

Elder JS, Diaz M.

Nat Rev Urol. 2013 Nov;10(11):640-8. doi: 10.1038/nrurol.2013.221. Epub 2013 Oct 15. Review.

PMID:
24126731
8.

The RIVUR trial: a factual interpretation of our data.

Mattoo TK, Carpenter MA, Moxey-Mims M, Chesney RW; RIVUR Trial Investigators.

Pediatr Nephrol. 2015 May;30(5):707-12. doi: 10.1007/s00467-014-3022-1. Epub 2015 Jan 6.

9.

What is the risk of urinary tract infection in children with antenatally presenting dilating vesico-ureteric reflux?

Evans K, Asimakadou M, Nwankwo O, Desai D, Cherian A, Mushtaq I, Cuckow P, Duffy P, Smeulders N.

J Pediatr Urol. 2015 Apr;11(2):93.e1-6. doi: 10.1016/j.jpurol.2015.01.009. Epub 2015 Mar 10.

PMID:
25819378
10.

Risk Factors for the Development of Bladder and Bowel Dysfunction.

Gaither TW, Cooper CS, Kornberg Z, Baskin LS, Copp HL.

Pediatrics. 2018 Jan;141(1). pii: e20172797. doi: 10.1542/peds.2017-2797.

11.

Long-term, low-dose prophylaxis against urinary tract infections in young children.

Brandström P, Hansson S.

Pediatr Nephrol. 2015 Mar;30(3):425-32. doi: 10.1007/s00467-014-2854-z. Epub 2014 Jun 7. Review.

PMID:
24906665
12.

Interventions for primary vesicoureteric reflux.

Nagler EV, Williams G, Hodson EM, Craig JC.

Cochrane Database Syst Rev. 2011 Jun 15;(6):CD001532. doi: 10.1002/14651858.CD001532.pub4. Review. Update in: Cochrane Database Syst Rev. 2019 Feb 20;2:CD001532.

PMID:
21678334
13.

Utility of the distal ureteral diameter on VCUG for grading VUR.

Cooper CS, Alexander SE, Kieran K, Storm DW.

J Pediatr Urol. 2015 Aug;11(4):183.e1-6. doi: 10.1016/j.jpurol.2015.04.009. Epub 2015 May 19.

PMID:
26189589
14.

The role of antimicrobial prophylaxis in the management of children with vesicoureteral reflux--the RIVUR study outcomes.

Mathews R, Mattoo TK.

Adv Chronic Kidney Dis. 2015 Jul;22(4):325-30. doi: 10.1053/j.ackd.2015.04.002. Review.

PMID:
26088078
15.

Vesicoureteral Reflux and Renal Scarring Risk in Children after the First Febrile Urinary Tract Infection.

Yılmaz S, Özçakar ZB, Kurt Şükür ED, Bulum B, Kavaz A, Elhan AH, Yalçınkaya F.

Nephron. 2016;132(3):175-80. doi: 10.1159/000443536. Epub 2016 Feb 23.

PMID:
26901769
16.

Bacterial pathogens in first febrile urinary tract infection affect breakthrough infections in infants with vesicoureteral reflux treated with prophylactic antibiotics.

Park S, Song SH, Lee C, Kim JW, Kim KS.

Urology. 2013 Jun;81(6):1342-5. doi: 10.1016/j.urology.2012.11.014. Epub 2013 Apr 4.

PMID:
23562584
17.

Treatment of recurrent complicated urinary tract infections in children with vesicoureteral reflux.

Wu TH, Huang FL, Fu LS, Chou CM, Chien YL, Huang CM, Lin CF, Chen PY.

J Microbiol Immunol Infect. 2016 Oct;49(5):717-722. doi: 10.1016/j.jmii.2014.08.024. Epub 2014 Nov 21.

18.

The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux.

Carpenter MA, Hoberman A, Mattoo TK, Mathews R, Keren R, Chesney RW, Moxey-Mims M, Greenfield SP; RIVUR Trial Investigators.

Pediatrics. 2013 Jul;132(1):e34-45. doi: 10.1542/peds.2012-2301. Epub 2013 Jun 10.

19.

Are prophylactic antibiotics indicated after a urinary tract infection?

Mattoo TK.

Curr Opin Pediatr. 2009 Apr;21(2):203-6. Review.

20.

Supplemental Content

Support Center